@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix Protein: . @prefix pfh: . @prefix geneProductOf: . @prefix go: . @prefix hgnc: . @prefix hasAgent: . @prefix species: . @prefix occursIn: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: pfh:FGF%20Family; a Protein: . sub:_2 hasAgent: sub:_3; a go:0016301 . sub:_3 geneProductOf: hgnc:3688; a Protein: . sub:_4 occursIn: species:9606; rdf:object sub:_2; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "p(PFH:\"FGF Family\") -> kin(p(HGNC:FGFR1))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_6; pav:version "1.4" . sub:_5 prov:value "As stated above, FGFs exert their biological activities by binding to high affinity tyrosine kinase FGFRs on the surface of target cells. In vitro, endothelial cells of different origin express FGFR1 [9,10] and, under some circumstances, FGFR2 [11] whereas the expression of FGFR3 or FGFR4 has never been reported in endothelium."; prov:wasQuotedFrom pubmed:15863032 . sub:_6 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:15863032; prov:wasDerivedFrom beldoc:, sub:_5 . } sub:pubinfo { this: dct:created "2014-07-03T14:30:34.756+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }